Search - tctmd.com

Displaying 821 - 840 of 1502

Sort: Relevancy | Date

Presentation TCT 2013

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

Presenter: Michael Joner

October 31, 2013

Presentation TCT 2013

The Evolution of Metallic DES: Are Patient Outcomes Improving?

Presenter: Stephan Windecker

October 31, 2013

Presentation TCT 2013

Synthesis of the Available Drug-Coated Balloon Clinical Data in BTK Intervention

Presenter: Dierk Scheinert

October 31, 2013

Presentation TCT 2013

RIBS IV-ISR Trial: Background and Trial Design

Presenter: Fernando Alfonso

October 31, 2013

Presentation TCT 2013

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

Presenter: Thomas Zeller

October 31, 2013

Presentation TCT 2013

PERFECT Stent: 3 Year Update

Presenter: Jochen W?hrle

October 31, 2013

Presentation TCT 2013

PEPCAD-China ISR Trial: 9-Month Angiographic and 1-Year Clinical Results

Presenter: Junbo Ge

October 31, 2013

Presentation TCT 2013

LEVANT 2

Presenter: D. Christopher Metzger

October 31, 2013

Presentation TCT 2013

ISAR DESIRE III Trial Update

Presenter: Robert Byrne

October 31, 2013

Presentation TCT 2013

Indigenous Stents: New Technologies and Clinical Data

Presenter: Sreenivas Kumar

October 31, 2013

Presentation TCT 2013

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Presenter: Gunnar Tepe

October 31, 2013

Presentation TCT 2013

Future Directions, Clinical Applications and Local Drug Delivery Technologies

Presenter: Juan Granada

October 31, 2013

Presentation TCT 2013

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Presenter: Clemens von Birgelen

October 31, 2013

Presentation TCT 2013

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Presenter: J?rg Schr?der

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Presenter: Ron Waksman

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Presenter: Christoph Naber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Presenter: Franz Kleber

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloon Mechanisms of Action: Insights From Angiography, FFR and OCT

Presenter: Pierfrancesco Agostoni

October 31, 2013

Presentation TCT 2013

Drug-Coated Balloon Mechanisms of Action: A Transparent Review of What We Don't Know

Presenter: Robert Schwartz

October 31, 2013

Advertisement

Vascular Healing in the Setting of Drug Deposition via Paclitaxel-Coated Balloon Delivery: Biological Implications for Device Development

The Evolution of Metallic DES: Are Patient Outcomes Improving?

Synthesis of the Available Drug-Coated Balloon Clinical Data in BTK Intervention

RIBS IV-ISR Trial: Background and Trial Design

PRO: Improved Vessel Patency Make Drug-Coated Balloons the Device of Choice for BTK Intervention!

PERFECT Stent: 3 Year Update

PEPCAD-China ISR Trial: 9-Month Angiographic and 1-Year Clinical Results

LEVANT 2

ISAR DESIRE III Trial Update

Indigenous Stents: New Technologies and Clinical Data

Impact of Lesion Complexity on Outcomes in Drug-Coated Balloon Trials: Implications for Device Selection and Future Trial Design

Future Directions, Clinical Applications and Local Drug Delivery Technologies

DUTCH PEERS (TWENTE II): A Prospective, Randomized, "All-Comers" Trial of Third-Generation Zotarolimus-Eluting Stents vs. Everolimus-Eluting Coronary Stents

Drug-Eluting Balloons vs. Everolimus-Eluting Stents for Treatment of In-Stent Restenosis

Drug-Coated Balloons in Small Vessel Coronary Artery Disease: Synthesis of BELLO and Other Studies

Drug-Coated Balloons in Patients with Diabetes: A Specific Niche?

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data(2)

Drug-Coated Balloons in Coronary Bifurcation Lesions: The Need, The Practice, The Data

Drug-Coated Balloon Mechanisms of Action: Insights From Angiography, FFR and OCT

Drug-Coated Balloon Mechanisms of Action: A Transparent Review of What We Don't Know

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content